Pulmonary Lobectomy After COVID-19

Ann Thorac Surg. 2021 Mar;111(3):e181-e182. doi: 10.1016/j.athoracsur.2020.08.004. Epub 2020 Sep 25.

Abstract

Concomitant coronavirus disease 19 (COVID-19) is a major risk factor for complications in any type of surgical procedure, especially in thoracic surgery, were the primary organ involved, the lung, is manipulated to perform parenchymal resection. However, it is not clear whether previous infection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may lead to increased morbidity and mortality for subsequent procedures once radiologic resolution is achieved. We report a young patient with lung cancer who successfully underwent a right upper lobectomy for primary adenocarcinoma by video-assisted thoracoscopic surgery with no complication in the early postoperative phase.

Publication types

  • Case Reports

MeSH terms

  • COVID-19 / epidemiology*
  • Carcinoma, Non-Small-Cell Lung / epidemiology
  • Carcinoma, Non-Small-Cell Lung / surgery*
  • Comorbidity
  • Humans
  • Lung Neoplasms / epidemiology
  • Lung Neoplasms / surgery*
  • Male
  • Middle Aged
  • Operative Time
  • Pandemics
  • Pneumonectomy / methods*
  • Postoperative Period
  • SARS-CoV-2*
  • Thoracic Surgery, Video-Assisted / methods*